Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Interleukin-6 Receptor Inhibitor Combined With Endovascular Treatment in Patients With Acute Anterior Circulation Large Vessel Occlusion Stroke: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial-2 (IRIS-2)

NCT07263776 is registered in ClinicalTrials.gov with Capital Medical University as lead sponsor.

NCT NCT07263776
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07263776 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Interleukin-6 Receptor Inhibitor Combined With Endovascular Treatment in Patients With Acute Anterior Circulation Large Vessel Occlusion Stroke: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial-2 (IRIS-2)
Lead sponsor
Capital Medical University
Phase
Phase 3
Overall status
Active, not recruiting
Start date
December 5, 2025
Completion date
June 11, 2027
Enrollment
692 (actual)
Sites
54

Conditions

As the registry lists them; a condition with its own page is linked.

acute ischemic stroke